The weekly litigation news digest is live. Subscribe now
The patent EP2720610 was granted to Abbott on Jul 16, 2025. The application was filed on Jun 18, 2012 under application number EP12801239A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
An analyte monitoring system that enables continuous glucose monitoring using a sensor connector to attach an analyte sensor to an electronics unit. The system includes a single-sided or double-sided analyte sensor with electrodes on one or both sides of a substrate, and a sensor connector that physically and electrically connects the sensor to the electronics unit. The sensor connector can be a rivet or other conductive material that connects the electrodes on one side of the sensor to the electronics unit, or a conductive rivet that connects electrodes on both sides of the sensor. The system enables continuous glucose monitoring by maintaining a stable connection between the sensor and electronics unit, and can be used with both in vivo and in vitro glucose monitoring applications.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent citations refer to prior patents cited during different phases such as opposition or international search.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents